2016
DOI: 10.1016/j.molmed.2016.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Oncometabolite Tinkers with Genome Folding, Boosting Oncogene Expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…Nothing, however, is known about its function in the brain or in relation to substance use disorders. In addition, this mark is usually studied in the context of enhancers (3335) and super-enhancers (3638), while its functional role in intragenic regions remains elusive. Even less is known about H3K23ac (39, 40) for which a group difference was noted for heroin, but the levels did not relate to drug history or acute use as they did for H3K27ac.…”
Section: Discussionmentioning
confidence: 99%
“…Nothing, however, is known about its function in the brain or in relation to substance use disorders. In addition, this mark is usually studied in the context of enhancers (3335) and super-enhancers (3638), while its functional role in intragenic regions remains elusive. Even less is known about H3K23ac (39, 40) for which a group difference was noted for heroin, but the levels did not relate to drug history or acute use as they did for H3K27ac.…”
Section: Discussionmentioning
confidence: 99%
“…The AhR pathway can cross talk with other major signaling pathways that might be modulated by oncometabolites that are critical in cancer progression 21 23 . We found elevated oncometabolite levels including 2-hydroxyglutarate (2-HG), α-ketoglutarate (α-KG), citrate, fumarate, malate, and succinate in A549-IR and HK1-IR cell sublines compared to P lines (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The AhR pathway can cross talk with other major signaling pathways that might be modulated by oncometabolites that are critical in cancer progression 21 23 . Diverse metabolites serve as cofactors or substrates for enzymes that are involved in the deposition or exchange of epigenetic marks, driving a metabolite-driven pathway of gene regulation as well as distinct cancer tissue types 24 , 57 59 .…”
Section: Discussionmentioning
confidence: 99%
“…Its mutants (i.e., SNPs rs7864322, rs12352658, rs7847449, and rs10759944) interact with a promoter shared by FOXE1 and PTCSC2 and act as enhancers [ 97 ]. Gliomas also display SNP-mediated interactions in which the oncogene PDGFRA is changed by CTCF-related chromosome folding [ 98 ]. Other interactions among enhancers, SNP rs73001406, and the DDX6 gene promoter affect cancer risk [ 99 ].…”
Section: Roles Of Chromosomal Conformations In Cancermentioning
confidence: 99%